Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

Monday’s Trading Day
151.78 -4.11 / -2.64%
As of Aug 31
Day’s Change
Tuesday’s Pre-Market   Switch to standard view »
148.61 -3.17 / -2.09%
 
Volume: 9.5K

Today’s Trading

Previous close155.89
Today’s open155.33
Day’s range151.30 - 156.35
Volume4,354,480
Average volume (3 months)3,536,712
Market cap$118.2B
Dividend yield2.08%
Data as of 08/31/2015

Growth & Valuation

Earnings growth (last year)+0.90%
Earnings growth (this year)+12.00%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+7.30%
P/E ratio20.1
Price/Sales6.12
Price/Book4.60

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-2.71-2.51%
BIIBBiogen-6.39-2.10%
BXLTBaxalta Inc-0.10-0.28%
BAXBaxter International...-0.30-0.77%
Data as of 08/31/2015

Financials

Next reporting dateOctober 26, 2015
EPS forecast (this quarter)$2.37
Annual revenue (last year)$20.0B
Annual profit (last year)$5.2B
Net profit margin25.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhu Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts

Partner Offers